BLFS

SEC source: 0001628280-26-024766 · wk-form4_1775856558.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 163,768

F1 · price: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

SEC source: 0001628280-26-024765 · wk-form4_1775856548.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 216,056

F1 · price: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

SEC source: 0001628280-26-022501 · wk-form4_1774991982.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality and Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 108,758

F1 · kind: The sales reported were effected pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 12-04-2025

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.99 to $19.35, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001628280-26-020581 · wk-form4_1774300146.xml · nonDerivative · entry 1

DE GREEF RODERICK · CIK 0001241181 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 733,746

F1 · price: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

SEC source: 0001628280-26-020580 · wk-form4_1774300140.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,061

F1 · price: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

SEC source: 0001628280-26-020579 · wk-form4_1774300132.xml · nonDerivative · entry 1

Werner Sean · CIK 0002047541 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,251

F1 · price: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

SEC source: 0001628280-26-020578 · wk-form4_1774300124.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 216,900

F1 · price: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

SEC source: 0001628280-26-020577 · wk-form4_1774300116.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,429

F1 · price: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

SEC source: 0001628280-26-020576 · wk-form4_1774300110.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality and Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,335

F1 · price: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

SEC source: 0001628280-26-020574 · wk-form4_1774300102.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 390,682

F1 · price: Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.

SEC source: 0001628280-26-016165 · wk-form4_1773094257.xml · nonDerivative · entry 2

Foster Karen A. · CIK 0001683151 · Chief Quality and Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,242

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.02, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001628280-26-016165 · wk-form4_1773094257.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality and Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,742

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.46, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

SEC source: 0001628280-26-015342 · wk-form4_1772748632.xml · nonDerivative · entry 1

Werner Sean · CIK 0002047541 · Chief Technology Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 49,932

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

SEC source: 0001628280-26-015341 · wk-form4_1772748626.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality and Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 210,665

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

SEC source: 0001628280-26-015340 · wk-form4_1772748620.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 392,937

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

SEC source: 0001628280-26-015339 · wk-form4_1772748614.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 220,649

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

SEC source: 0001628280-26-015337 · wk-form4_1772748608.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 93,360

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

SEC source: 0001628280-26-015336 · wk-form4_1772748602.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 165,940

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 02-24-2022 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

SEC source: 0001628280-26-012481 · wk-form4_1772146575.xml · nonDerivative · entry 3

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 166,293

F3 · price: Represents shares withheld to cover tax withholding obligations in connection with the vesting of the market-based restricted stock award.

SEC source: 0001628280-26-012481 · wk-form4_1772146575.xml · nonDerivative · entry 2

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 175,139

F2 · price: The restricted stock was granted pursuant to the 2023 Plan. In accordance with the terms of the grant, the restricted stock vested as to approximately 156% of the number of shares granted based on the registrant's total shareholder return during the period beginning on January 1, 2024 through December 31, 2025 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date).

SEC source: 0001628280-26-012481 · wk-form4_1772146575.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 152,660

F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the "2023 Plan") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2026 compensation.

SEC source: 0001628280-26-012480 · wk-form4_1772146569.xml · nonDerivative · entry 1

DuRoss Amy · CIK 0001854968 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,857

F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan and fully vests on the first anniversary of the vesting date of January 2, 2026

SEC source: 0001628280-26-012479 · wk-form4_1772146564.xml · nonDerivative · entry 3

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 221,237

F3 · price: Represents shares withheld to cover tax withholding obligations in connection with the vesting of the market-based restricted stock award.

SEC source: 0001628280-26-012479 · wk-form4_1772146564.xml · nonDerivative · entry 2

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 246,762

F2 · price: The restricted stock was granted pursuant to the 2023 Plan. In accordance with the terms of the grant, the restricted stock vested as to approximately 156% of the number of shares granted based on the registrant's total shareholder return during the period beginning on January 1, 2024 through December 31, 2025 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date).

SEC source: 0001628280-26-012479 · wk-form4_1772146564.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 181,896

F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the "2023 Plan") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2026 compensation.

SEC source: 0001628280-26-012477 · wk-form4_1772146552.xml · nonDerivative · entry 1

Coste Catherine · CIK 0001821432 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,871

F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan and fully vests on the first anniversary of the vesting date of January 2, 2026.

SEC source: 0001628280-26-012478 · wk-form4_1772146558.xml · nonDerivative · entry 1

Hunt Anthony · CIK 0001606030 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,046

F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan and fully vests on the first anniversary of the vesting date of January 2, 2026

SEC source: 0001628280-26-012476 · wk-form4_1772146544.xml · nonDerivative · entry 1

Ellingson Rachel · CIK 0001557271 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,995

F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan and fully vests on the first anniversary of the vesting date of January 2, 2026

SEC source: 0001628280-26-012474 · wk-form4_1772146538.xml · nonDerivative · entry 5

DE GREEF RODERICK · CIK 0001241181 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 744,847

F5 · price: Represents shares withheld to cover tax withholding obligations in connection with the vesting of the performance-based restricted stock award.

SEC source: 0001628280-26-012474 · wk-form4_1772146538.xml · nonDerivative · entry 4

DE GREEF RODERICK · CIK 0001241181 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 831,033

F4 · price: The restricted stock was granted pursuant to the 2023 Plan. In accordance with the terms of the grant, the restricted stock vested as to 200% of the number of shares granted based on specific performance metrics of the registrant during the period beginning on January 1, 2024 through December 31, 2025.

SEC source: 0001628280-26-012474 · wk-form4_1772146538.xml · nonDerivative · entry 3

DE GREEF RODERICK · CIK 0001241181 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 612,009

F3 · price: Represents shares withheld to cover tax withholding obligations in connection with the vesting of the market-based restricted stock award.

SEC source: 0001628280-26-012474 · wk-form4_1772146538.xml · nonDerivative · entry 2

DE GREEF RODERICK · CIK 0001241181 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 679,019

F2 · price: The restricted stock was granted pursuant to the 2023 Plan. In accordance with the terms of the grant, the restricted stock vested as to approximately 156% of the number of shares granted based on the registrant's total shareholder return during the period beginning on January 1, 2024 through December 31, 2025 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date).

SEC source: 0001628280-26-012474 · wk-form4_1772146538.xml · nonDerivative · entry 1

DE GREEF RODERICK · CIK 0001241181 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 508,728

F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the "2023 Plan") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2026 compensation.

SEC source: 0001628280-26-012473 · wk-form4_1772146532.xml · nonDerivative · entry 3

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 393,466

F3 · price: Represents shares withheld to cover tax withholding obligations in connection with the vesting of the market-based restricted stock award.

SEC source: 0001628280-26-012473 · wk-form4_1772146532.xml · nonDerivative · entry 2

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 409,051

F2 · price: The restricted stock was granted pursuant to the 2023 Plan. In accordance with the terms of the grant, the restricted stock vested as to approximately 156% of the number of shares granted based on the registrant's total shareholder return during the period beginning on January 1, 2024 through December 31, 2025 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date).

SEC source: 0001628280-26-012473 · wk-form4_1772146532.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 369,446

F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan (the "2023 Plan") and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2026 compensation.

SEC source: 0001628280-26-012472 · wk-form4_1772146526.xml · nonDerivative · entry 2

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 93,579

F2 · price: Represents shares withheld to cover tax withholding obligations in connection with the vesting of the market-based restricted stock award.

SEC source: 0001628280-26-012472 · wk-form4_1772146526.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,313

F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan. In accordance with the terms of the grant, the restricted stock vested as to approximately 156% of the number of shares granted based on the registrant's total shareholder return during the period beginning on January 1, 2024 through December 31, 2025 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date).

SEC source: 0001628280-26-012471 · wk-form4_1772146521.xml · nonDerivative · entry 1

Werner Sean · CIK 0002047541 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,043

F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of 2026 compensation.

SEC source: 0001628280-26-012470 · wk-form4_1772146515.xml · nonDerivative · entry 1

MOORE TIMOTHY L. · CIK 0001669207 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 44,943

F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan and fully vests on the first anniversary of the vesting date of January 2, 2026

SEC source: 0001628280-26-012469 · wk-form4_1772146509.xml · nonDerivative · entry 2

Foster Karen A. · CIK 0001683151 · Chief Quality and Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 211,083

F2 · price: Represents shares withheld to cover tax withholding obligations in connection with the vesting of the market-based restricted stock award.

SEC source: 0001628280-26-012469 · wk-form4_1772146509.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality and Operations

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 224,096

F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan. In accordance with the terms of the grant, the restricted stock vested as to approximately 156% of the number of shares granted based on the registrant's total shareholder return during the period beginning on January 1, 2024 through December 31, 2025 as compared to the total shareholder return of certain of the registrant's peers (such peers have been determined by the registrant's compensation committee with assistance of an outside consultant immediately prior to the grant date).

SEC source: 0001628280-26-012468 · wk-form4_1772146503.xml · nonDerivative · entry 1

GOSWAMI JOYDEEP · CIK 0001533115 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 53,156

F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan and fully vests on the first anniversary of the vesting date of January 2, 2026

SEC source: 0001628280-26-001387 · wk-form4_1767909868.xml · nonDerivative · entry 1

Wichterman Troy · CIK 0001892616 · Chief Financial Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 150,746

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

SEC source: 0001628280-26-001385 · wk-form4_1767909860.xml · nonDerivative · entry 1

Foster Karen A. · CIK 0001683151 · Chief Quality and Operations

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 191,984

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

SEC source: 0001628280-26-001384 · wk-form4_1767909852.xml · nonDerivative · entry 1

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 75,765

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

SEC source: 0001628280-26-001383 · wk-form4_1767909839.xml · nonDerivative · entry 1

Mathew Aby J. · CIK 0001556355 · EVP & Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 349,350

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

SEC source: 0001628280-26-001382 · wk-form4_1767909830.xml · nonDerivative · entry 1

Berard Todd · CIK 0001633186 · Chief Marketing Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 132,564

F1 · kind: The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 01-03-2023 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

SEC source: 0001628280-25-057722 · wk-form4_1766010365.xml · nonDerivative · entry 2

Aebersold Sarah · CIK 0001837756 · Chief Human Resources Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 76,006

SEC source: 0001628280-25-057721 · wk-form4_1766010355.xml · nonDerivative · entry 1

DuRoss Amy · CIK 0001854968 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,687